World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00917345
Date of registration: 08/06/2009
Prospective Registration: No
Primary sponsor: National Taiwan University Hospital
Public title: Diagnosis of Primary Aldosteronism: Comparison of Post Captopril Active Renin Concentration and Plasma Renin Activity
Scientific title:
Date of first enrolment: January 2008
Target sample size: 150
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00917345
Study type:  Observational
Study design:  Observational Model: Case Control, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Taiwan
Contacts
Name:     VinCent Wu, MD
Address: 
Telephone: +886927223278
Email: q91421028@ntu.edu.tw
Affiliation: 
Name:     VinCent Wu, MD
Address: 
Telephone: +886937223278
Email:
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

1. age at onset younger than 35 years,

2. hypertension that is difficult to control after initiating therapy,

3. clinical occurrence of a hypertensive crisis,

4. the presence of hypokaliemia or metabolic alkalosis, or a random aldosterone-renin
ration (ARR) >30, and

5. evidence of adrenal incidentaloma and hypertension or hypokalemia.

Exclusion Criteria:

1. chronic kidney disease with elevated estimated glomerular filtration rate (< 60,
mL/min/1.73 m2)

2. liver disease with elevated GPT (> 35)

3. heart failure

4. classified as more than NYHA II,

5. hyperthyroidism

6. malignancy with metastasis



Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Primary Aldosteronism
Intervention(s)
Drug: captopril test
Primary Outcome(s)
Determination of ARC in contrast to PRA offers advantage with regard to processing and standardization, knowing the postcaptopril sensitivity and specificity [Time Frame: 1 day]
Secondary Outcome(s)
Secondary ID(s)
200904076R
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Novartis
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history